Gyre Therapeutics, Inc. (GYRE)
4.555
-1.86
(-28.94%)
USD |
NASDAQ |
Oct 30, 16:00
4.64
+0.08
(+1.87%)
After-Hours: 20:00
Gyre Therapeutics Market Cap : 482.98M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 482.98M |
| October 29, 2026 | 679.68M |
| October 28, 2026 | 751.78M |
| October 27, 2026 | 692.40M |
| October 26, 2026 | 643.63M |
| October 23, 2026 | 620.30M |
| October 22, 2026 | 621.36M |
| October 21, 2026 | 625.60M |
| October 20, 2026 | 654.23M |
| October 19, 2026 | 645.75M |
| October 16, 2026 | 644.69M |
| October 15, 2026 | 678.62M |
| October 14, 2026 | 686.04M |
| October 13, 2026 | 711.49M |
| October 12, 2026 | 727.92M |
| October 09, 2026 | 746.48M |
| October 08, 2026 | 716.79M |
| October 07, 2026 | 746.48M |
| October 06, 2026 | 750.72M |
| October 05, 2026 | 779.35M |
| October 02, 2026 | 753.90M |
| October 01, 2026 | 742.24M |
| September 30, 2026 | 777.23M |
| September 29, 2026 | 776.17M |
| September 28, 2026 | 794.19M |
| Date | Value |
|---|---|
| September 25, 2026 | 779.35M |
| September 24, 2026 | 777.23M |
| September 23, 2026 | 784.65M |
| September 22, 2026 | 794.19M |
| September 21, 2026 | 787.83M |
| September 18, 2026 | 800.56M |
| September 17, 2026 | 761.32M |
| September 16, 2026 | 710.43M |
| September 15, 2026 | 709.37M |
| September 14, 2026 | 709.37M |
| September 11, 2026 | 713.61M |
| September 10, 2026 | 714.67M |
| September 09, 2026 | 736.93M |
| September 08, 2026 | 760.26M |
| September 04, 2026 | 727.39M |
| September 03, 2026 | 682.86M |
| September 02, 2026 | 674.38M |
| September 01, 2026 | 686.04M |
| August 31, 2026 | 696.64M |
| August 28, 2026 | 698.76M |
| August 27, 2026 | 708.31M |
| August 26, 2026 | 705.12M |
| August 25, 2026 | 708.31M |
| August 24, 2026 | 682.86M |
| August 21, 2026 | 732.69M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 8.741B |
| Incyte Corp. | 24.20B |
| ACADIA Pharmaceuticals, Inc. | 3.544B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 280.37M |
Market Cap Related Metrics
| PS Ratio | 3.692 |
| PEG Ratio | -0.0142 |
| Price to Book Value | 4.475 |
| Price | 4.555 |
| Earnings Yield | -4.30% |
| PEGY Ratio | -0.0142 |